| Octaplex Powder and Solvent for Solution for Injection 500 IUCombinatie | 🇸🇬Singapore | 280 - 760 IU/vial + 500 IU/vial + 180 - 480 IU/vial + 360 - 600 IU/vial + 260 - 620 IU/vial + 240 - 640 IU/vial | injection, powder, for solution | Toegelaten | Wellchem Pharmaceuticals Pte LTD |
| Hexaxim Suspension for Injection in Pre-Filled SyringeCombinatie | 🇸🇬Singapore | 30 Lf (>= 20 IU)/0.5 mL + 25 μg/0.5 mL + 12 μg/0.5 mL + 10 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + 10 Lf (>= 40 IU)/0.5 mL | injection, suspension | Toegelaten | Sanofi-Aventis Singapore Pte. LTD. |
| Prevenar 13 Suspension For InjectionCombinatie | 🇸🇬Singapore | 32mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 2.2mcg + 4.4mcg + 2.2mcg + 2.2mcg | injection, suspension | Toegelaten | Pfizer Private Limited |
| Prevenar 20 Suspension for Injection in Single-Dose Pre-Filled Syringe 0.5MLCombinatie | 🇸🇬Singapore | Approx. 51 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 4.4 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml + 2.2 μg/0.5ml | injection, suspension | Toegelaten | Pfizer Private Limited |
| Megalotect CP Solution for Infusion 100 U/ML | 🇸🇬Singapore | 100 U/ml | injection | Toegelaten | Grifols Asia Pacific Pte. LTD. |
| Pentaxim VaccineCombinatie | 🇸🇬Singapore | min. 20 IU (30 Lf)/0.5 mL + 25 μg/0.5 mL + 25 μg/0.5 mL + 29 DU/0.5 mL + 7 DU/0.5 mL + 26 DU/0.5 mL + min. 40 IU (10 Lf) /0.5 mL + 10 μg/0.5 mL + 18 - 30 μg/0.5 mL | injection, powder, for suspension | Toegelaten | Sanofi-Aventis Singapore Pte. LTD. |
| Synflorix Suspension for Injection (Prefilled Syringe)Combinatie | 🇸🇬Singapore | 1 μg PS1; 1.11-1.67 μg PD/dose + 1 μg PS14; 1.00-1.82 μg PD/dose + 3 μg PS18C; 5.45-10.00 μg TT/dose + 3 μg PS19F; 3.33-6.00 μg DT/dose + 1 μg PS23F; 0.39-0.74 μg PD/dose + 3 μg PS4; 3.33-6.67 μg PD/dose + 1 μg PS5; 0.67-1.25 μg PD/dose + 1 μg PS6B; 0.56-0.95 μg PD/dose + 1 μg PS7F; 0.87-1.43 μg PD/dose + 1 μg PS9V; 1.00-1.82 μg PD/dose + 3-6 μg DT/dose (total DT content) + 16 μg/dose (total PS content) + 9-16 μg PD/dose (total PD content) + 5-10 μg/dose | injection, suspension | Toegelaten | Glaxosmithkline Pte LTD |
| Xeomin® Powder for Solution for Injection 50 Units/Vial | 🇸🇬Singapore | 50 LD50 units | injection, powder, for solution | Toegelaten | Merz Asia Pacific Pte. LTD. |
| Xeomin® Powder for Solution for Injection 100 Units/Vial | 🇸🇬Singapore | 100 LD50 units | injection, powder, for solution | Toegelaten | Merz Asia Pacific Pte. LTD. |
| Nuvaxovid Dispersion for Injection COVID19 Vaccine 5mcg/dose (recombinant, adjuvanted) in PFS | 🇸🇬Singapore | 5 mcg/0.5ml | injection, suspension | Toegelaten | Sanofi-Aventis Singapore Pte. LTD. |
| Tisseel Fibrin Sealant VH S/D (Frozen)Combinatie | 🇸🇬Singapore | 2250-3750 KIU/ml + 36-44 umol/ml + 72-110 mg/ml + 400-625 IU/ml | solution | Toegelaten | Baxter Healthcare (Asia) Pte LTD |
| NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV | 🇸🇬Singapore | 5 mcg/dose | injection, suspension | Toegelaten | Sanofi-Aventis Singapore Pte. LTD. |
| Menveo Powder and Solution for Solution for InjectionCombinatie | 🇸🇬Singapore | 10 microgram conjugated to 16.7-33.3 microgram + 5 microgram conjudated to 7.1-12.5 microgram + 5 microgram conjugated to 3.3-8.3 microgram + 5 microgram conjugated to 5.6-10 microgram | injection, powder, for solution | Toegelaten | Glaxosmithkline Pte LTD |
| Hepatect CP Solution for Infusion 50 IU/ML | 🇸🇬Singapore | 50 iu/ml | infusion, solution | Toegelaten | Grifols Asia Pacific Pte. LTD. |
| Uman Albumin Solution for Infusion 200 g/l | 🇸🇬Singapore | 200 g/l | infusion, solution | Toegelaten | Euro Asia Medico Pte. LTD. |
| Nimenrix Powder and Solvent for Solution for InjectionCombinatie | 🇸🇬Singapore | 5 micrograms + 5 micrograms + 5 micrograms + 5 micrograms + ~44 micrograms | injection, powder, for solution | Toegelaten | Pfizer Private Limited |
| NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) | 🇸🇬Singapore | 5 µg/dose | injection, suspension | Toegelaten | Sanofi-Aventis Singapore Pte. LTD. |
| Artiss Solutions for Sealant, Deep FrozenCombinatie | 🇸🇬Singapore | 2250 – 3750 KIU/ml + 36 – 44 μmol/ml + 72 – 110 mg/ml + 3.2– 5.0 IU/ml | solution | Toegelaten | Baxter Healthcare (Asia) Pte LTD |
| Ig VENA Solution for Infusion 50g/l | 🇸🇬Singapore | 50mg/ml | infusion, solution | Toegelaten | Euro Asia Medico Pte. LTD. |
| Infanrix Ipv+Hib VaccineCombinatie | 🇸🇬Singapore | min 30IU/0.5ml + 25mcg/0.5ml + 10 mcg/0.5 ml + 8mcg/0.5ml + 25mcg/0.5ml + 40DU/0.5ml + 8DU/0.5ml + 32DU/0.5ml + min 40IU/0.5ml | injection | Toegelaten | Glaxosmithkline Pte LTD |
| Intratect solution for infusion 50g/l | 🇸🇬Singapore | 50 mg/ml | infusion, solution | Toegelaten | Grifols Asia Pacific Pte. LTD. |
| Menquadfi Solution for InjectionCombinatie | 🇸🇬Singapore | 10 mcg/ 0.5 mL + 10 mcg/ 0.5 mL + 10 mcg / 0.5mL + 10 mcg/ 0.5 mL + 55 mcg/ 0.5 mL | injection, solution | Toegelaten | Sanofi-Aventis Singapore Pte. LTD. |
